Eastland Memorial Hospital is implementing Prognosis Health Information Systems' ChartAccess Comprehensive EHR to help meet meaningful use incentives.

If these are challenging times for healthcare, things are also moving fast, and its important that health IT efforts include a focus on delivering care to underserved communities, Garth Graham, MD, MPH, deputy assistant secretary for minority health in the U.S. Department of Health and Human Services Office of Minority Health, said in an interview.

The University of Massachusetts (UMass) at Amhersts University Health Services (UHS) has disclosed that a malware-infected workstation may have put some patients protected health information (PHI) at risk between June 30 and Sept. 29, 2010, according to a March 7 letter posted on the UHS website. UHS is the university's campus health center, offering care, education and referral services for students, faculty and staff.

A recent report by the Millennium Research Group, which predicted increases in imaging device sales as a result of healthcare reform, got some upbeat reinforcement this week, when market research firm Kalorama announced new predictions for growth in a related field in a report. Whats good for advanced visualization, is, apparently, also good for virtual reality.

Medical visualization software that allows multiple physicians to consult on a patients condition is one of the key areas of growth for virtual reality (VR) technologies in healthcare, according to a study by Kalorama Information.

Grace Community Health Center, of Gray, Ky., has secured in excess of $150,000 in state Medicaid incentives by demonstrating its recent selection of NextGen Healthcares certified ambulatory EHR tool.

Beloit, Wis.-based Beloit Health System has extended its partnership with TeleHealth Services to provide interactive patient education and entertainment in the hospitals Experience the Difference patient care initiative.

Patients receiving triple-antiplatelet therapy after long zotarolimus-eluting stent implantation had decreased extent of late luminal loss, percent intimal hyperplasia volume and angiographic restenosis, resulting in a reduced risk of one-year target lesion revascularization compared with patients receiving dual-antiplatelet therapy, according to the DECLARE-LONG trial in the March 15 issue of the Journal of the American College of Cardiology.